
CIRM awards $7.4m for novel Freidreich’s ataxia therapy
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia. The funding, awarded to a team at the University of California San Diego, will help researchers complete the final steps required by federal regulators before they… Read More










